Skip to main content

Support for Use of Naloxone and Other Opioid Overdose Reversal Medications to Prevent Overdose Deaths

Description:

Monitoring the distribution and impact of opioid overdose reversal medications such as naloxone is essential to optimizing overdose prevention strategies and improving public health outcomes. This Statistical Data Profile, the first to use performance data from two SAMHSA grant programs, examines the distribution of FDA-approved opioid overdose reversal medications, including naloxone/Narcan. The Data Profile also presents the training of first responders, community organization staff and other individuals to administer the reversal medications and provide other support services.

Publication Date:
March 31, 2025
Collection Date:
2017-2024
Data Source:
Report Type:
Short Report
< Back to Main content